Secondary Logo

Journal Logo

BRIEF REPORTS

FATAL COXSACKIEVIRUS A16 INFECTION

Wang, Chung-Yi M.D.; Li Lu, Frank M.D.; Wu, Mei-Hwan M.D., Ph.D.; Lee, Chin-Yun M.D., Ph.D.; Huang, Li-Min M.D., Ph.D.

Author Information
The Pediatric Infectious Disease Journal: March 2004 - Volume 23 - Issue 3 - p 275-276
doi: 10.1097/01.inf.0000115950.63906.78
  • Free

Abstract

Hand, foot and mouth disease (HFMD) is usually caused by the coxsackievirus (CoX) and is common in children. 1 Since 1998 we have observed fatal cases of enterovirus infection in Taiwan mainly involving enterovirus 71 (EV71) in infants. 2 EV71 infection has become an endemic disease in this region with occasional spikes in incidence. Based on an outbreak in Taiwan in 1998, CoX A16 infection is usually self-limited without associated fatality. Only two fatal cases have been reported in the literature since 1960. 3, 4 We report here a fatal case of CoX A16 infection in a 15-month-old boy.

Case report.

A 15-month-old boy was admitted to National Taiwan University Hospital because of seizures with shock. Intermittent high spiking fever associated with poor oral intake was noted for 3 days. Many small ulcers and vesicles over his posterior pharyngeal wall were noted by a local medical doctor on the second day. Meanwhile, small vesicles were found on his hands, feet and buttocks. His physician diagnosed hand, foot and mouth disease and prescribed symptomatic medication. Nevertheless poor activity, appetite and fever persisted. Sudden loss of consciousness, upward gazing and tonic convulsions were noted on the third day of illness. On admission weak pulses and lip cyanosis were observed. He was intubated and transferred to our pediatric intensive care unit for further care.

On admission his pulse rate was 187 beats/min and his blood pressure was 64/32 mm Hg. His consciousness level deteriorated gradually. Fine rales and wheezing were audible at both lung bases. His liver and spleen were not palpable.

The routine laboratory studies were normal including: serum sodium, 132 mmol/l; potassium, 5.09 mmol/l; chloride, 104 mmol/l; and normal urinalysis except that the urine protein was 100 mg/dl; urine sugar was 0.25 g/dl. Abnormalities on blood tests were elevated white blood cell counts of 21 540/μl with band cells of 8%, segment cells of 40% and lymphocytes of 48%. Blood glucose was 390 mg/dl. The initial creatine kinase was 183 units/l; creatine kinase-myocardial band was 34.5 units/l and troponin-I was 16.2 ng/ml. Poor cardiac contractivity was detected by cardiac echography. Severe myocarditis was suspected. Lumbar puncture showed pleocytosis. Cell counts of cerebrospinal fluid were 158, and lymphocyte/neutrophil counts were 111/47. His blood and cerebrospinal fluid cultures were sterile. A roentgenogram of the chest showed borderline cardiomegaly with perihilar congestion of the lung fields.

He was given inotropic agents (dopamine, dobutamin, norepinephrine, epinephrine) and frequent fluid challenge, but his blood pressure remained low (mean arterial pressure ∼40 mm Hg) and unresponsive to these medications. Follow-up chest radiographs revealed progressive cardiomegaly and congestion in the lung fields. The child received extracorporeal membrane oxygenation on the fourth day of illness. Intravenous immunoglobulin was given for 2 days (1 g/kg/day). Progressive dilated pupils and oliguria were noted. He died on the sixth day of illness.

Both throat and rectal viral cultures yielded enterovirus. This strain was confirmed to be coxsackievirus A16 by monoclonal antibody fluorescence and a standard neutralization test. 5

Discussion.

HFMD is a common illness in children and may be related to coxsackie viruses A16, A5, A9, A10, B2, B5 and enterovirus 71. 1, 6–12 CoX A16 is a frequently encountered pathogen in cases of HFMD, and its clinical course is usually uneventful, with full recovery. 6 Most cases occur in the summer and fall, and the incubation period is 4 to 6 days. Infection is highly contagious. 13 A literature search revealed only two fatal cases in infants since 1963. 3, 4

In 1963 Wright et al. 3 presented a fatal case of a 10-month-old girl with respiratory infection, culminating in severe cardiac failure. The CoX A16 was isolated from the intestines but not from the myocardium. A severe inflammatory process in the myocardium was documented from microscopic sections at autopsy. The second case involved a 7-month-old boy with grunting and tongue ulcers. 4 The patient died 4 days after onset of clinical manifestations of irritability, respiratory distress, tachycardia, cyanosis and convulsion. Gross pathology suggested encephalitis and myocarditis, and CoX A16 was isolated from the myocardium, blood and bowel contents.

The clinical manifestations of fatal CoX A 16 infection as seen in our patient and the two cases from the medical literature are similar to those of coxsackievirus B infection, 14 occurring mainly in newborns. Fatal cases of coxsackievirus A infection in infants is rare.

Since the outbreak in Taiwan in 1998, EV71 has been the single most prominent pathogen associated with severe morbidity or mortality. 2 Among the enterovirus isolates, EV 71 and CoX A16 were the two most prevalent at that time, and they were associated with similar symptoms and signs. 15 However, EV71 illness was more severe and had serious complications including death, whereas CoX A16 infection was self-limited. 1, 15

Myocarditis caused by coxsackievirus group B is well-established. 16 Since 1954 coxsackievirus group A viruses, such as A1, A4 and A9, have been associated with myocarditis. 17–19 echovirus, group B coxsackievirus and CoX A16 have been reported to cause fatalities in the neonatal period. 20 Most CoX A16 infections are uncomplicated or involve only aseptic meningitis. 9 Our case presented as fulminant myocarditis with intractable shock, a rare condition. The possible cause of our patient’s death was myocardial failure.

1. Chang LY, Lin TY, Hsu KH, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 1999; 353: 1682–6.
2. CDC. Deaths among children: an outbreak of hand, foot, and mouth disease: Taiwan, Republic of China, April–July 1998. MMWR 1998; 47: 629–32.
3. Wright HT, Landing BH, Lennette EH, McAllister RM. Fatal infection in an infant associated with coxsackie virus group A, type 16. N Engl J Med 1963; 268: 1041–4.
4. Goldberg MF, McAdams AJ. Myocarditis possibly due to coxsackie group A, type 16, virus. J Pediatr 1963; 62: 762–5.
5. Cherry JD, Jahn CL. Hand, foot, and mouth syndrome: report of six cases due to coxsackie virus, group A, type 16. Pediatrics 1966; 37: 637–43.
6. Barlean L, Avram G, Pavlov E, Cotor F. Investigation of five cases of vesicular enteroviral stomatitis with exanthema induced by coxsackie A5 virus. Rev Roum Virol 1994; 45: 3–9.
7. Foreschle JE, Nahmias AJ, Feorino PM, McCord G, Naib Z. Hand, foot and mouth disease (coxsackie virus A16) in Atlanta. Am J Dis Child 1967; 114: 278–83.
8. Baker DA, Phillips CA. Fatal hand-foot-and-mouth disease in an adult caused by Coxsackievirus A7. JAMA 1979; 242: 1065.
9. Hugghes RO, Robers C. Hand, foot, and mouth disease associated with Coxsackie A9 virus. Lancet 1972; 2: 751–2.
10. Itagaki A, Ishihara J, Mochida K, et al. A clustering outbreak of hand, foot, and mouth disease caused by coxsackie virus A10. Microbiol Immunol 1983; 27: 929–35.
11. Phillips CA, Aronson MD, Tomkow J, Phillips ME. Enteroviruses in Vermont, 1969–1978: an important cause of illness throughout the year. J Infect Dis 1980; 141: 162–4.
12. Ishimaru Y, Nakano S, Yamaoka K, Takami S. Outbreaks of hand, foot, and mouth disease by enterovirus 71: high incidence of complication disorders of central nervous system. Arch Dis Child 1980; 55: 583–8.
13. Cherry JD, Nelson DB. Enterovirus infections: their epidemiology and pathogenesis. Clin Pediatr 1966; 5: 659–64.
14. Sussman ML, Strauss L, Hodes HL. Fatal coxsackie group B virus infection in newborn: report of case with necropsy findings and a brief review of the literature. J Dis Child 1959; 97: 483–92.
15. Chang LY, Lin TY, Huang YC, et al. Comparison of enterovirus 71 and coxsackievirus A16: clinical illness during the Taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J 1999; 18: 1092–6.
16. Burch GE, Sun SC, Chu K, et al. Interstitial and coxsackie virus B myocarditis in infants and children. JAMA 1968; 203: 1–8.
17. Hosier DM, Newton WA. Serious coxsackie infection in infants and children. AMA J Dis Child 1958; 96: 251–7.
18. Movitt ER, Lennette EH, Mangum JF, Berk M, Bowman MS. Acute benign pericarditis: report of two cases associated with group A and group B coxsackie viruses. N Engl J Med 1958; 258: 1082–6.
19. Gold E, Carver DH, Heeneberg H, Adelson L, Robbins FC. Viral infection: a possible cause of sudden unexpected death in infants. N Engl J Med 1961; 264: 53–60.
20. Wreghitt TG, Sutehall GM, King A, Gandy GM. Fatal echovirus 7 infection during an outbreak in a special care baby unit. J Infect 1989; 19: 229–36.
Keywords:

Enterovirus; coxsackievirus A16; fatality

© 2004 Lippincott Williams & Wilkins, Inc.